Related Experiment Video
Updated: Apr 20, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy
Mireia Alcalde1, Oscar Campuzano, Georgia Sarquella-Brugada
1Cardiovascular Genetics Centre, IDIBGI-University of Girona, C/Pic de Peguera 11, 17003, Girona, Spain.
Insights
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart condition causing fibrofatty tissue replacement. Genetic advances aid in diagnosing ARVC, improving clinical practice for this condition linked to sudden cardiac death.
Area of Science:
- Cardiology
- Genetics
- Inherited Cardiac Diseases
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a primary inherited cardiac disease.
- It involves fibrofatty replacement of the myocardium, predominantly in the right ventricle.
- ARVC can lead to sudden cardiac death, particularly in young males during physical activity.
Purpose of the Study:
- To review recent genetic advances in arrhythmogenic right ventricular cardiomyopathy.
- To discuss the interpretation and clinical application of genetic data in ARVC diagnosis.
- To address the challenge of genetic variants of unknown significance in ARVC.
Main Methods:
- Review of current literature on ARVC genetics.
- Analysis of genetic technologies and their impact on ARVC diagnosis.
- Discussion of gene-disease associations and variant interpretation.
Main Results:
- Thirteen genes are currently associated with ARVC.
- Approximately 40% of clinically diagnosed ARVC cases lack a genetic diagnosis.
- New genetic technologies generate substantial data on novel genes, often of ambiguous significance.
Conclusions:
- Genetic testing is crucial for diagnosing ARVC.
- Advances in genetic analysis are improving diagnostic yield.
- Effective interpretation of genetic data is essential for clinical practice in ARVC.
Abstract:
Arrhythmogenic right ventricular cardiomyopathy is an inherited cardiac entity characterized by right ventricular, or biventricular, fibrofatty replacement of myocardium. Structural alterations may lead to sudden cardiac death, mainly in young males during exercise. Autosomal dominant pattern of inheritance is reported in most parts of pathogenic genetic variations identified. Currently, 13 genes have been associated with the disease but nearly 40 % of clinically diagnosed cases remain without a genetic diagnosis. New genetic technologies allow further genetic analysis, generating a significant amount of genetic data in novel genes, which is often classified as of ambiguous significance. We focus on genetic advances of arrhythmogenic right ventricular cardiomyopathy, helping clinicians to interpret and translate genetic data into clinical practice.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Mechanism of Cardiac Arrhythmias